NASDAQ:MASI - Masimo Stock Price, Forecast & News

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Masimo Co. (NASDAQ:MASI) announced its earnings results on Wednesday, October, 30th. The medical equipment provider reported $0.76 earnings per share for the quarter, beating analysts' consensus estimates of $0.73 by $0.03. The medical equipment provider earned $229.01 million during the quarter, compared to analyst estimates of $221.92 million. Masimo had a net margin of 20.83% and a return on equity of 17.32%. The company's quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.71 EPS. View Masimo's Earnings History.

Masimo is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Masimo.

Masimo will be holding an earnings conference call on Wednesday, February 19th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Masimo updated its FY 2019 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided earnings per share guidance of 3.18 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.17. The company issued revenue guidance of $934-937 million, compared to the consensus revenue estimate of $947.01 million.

6 analysts have issued twelve-month target prices for Masimo's stock. Their forecasts range from $134.50 to $190.00. On average, they expect Masimo's stock price to reach $167.08 in the next year. This suggests that the stock has a possible downside of 1.7%. View Analyst Price Targets for Masimo.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Masimo.

Media headlines about MASI stock have trended positive this week, InfoTrie reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Masimo earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Masimo.

Masimo saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,530,000 shares, an increase of 166.3% from the December 15th total of 574,600 shares. Based on an average daily trading volume, of 285,000 shares, the days-to-cover ratio is presently 5.4 days. Currently, 3.1% of the company's stock are sold short. View Masimo's Current Options Chain.

Some companies that are related to Masimo include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and Steris (STE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Mastercard (MA), Alibaba Group (BABA), Paypal (PYPL), Twilio (TWLO), Visa (V), Shopify (SHOP) and Intuitive Surgical (ISRG).

Masimo's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Scout Investments Inc. (0.40%), Boston Trust Walden Corp (0.25%), Mckinley Capital Management LLC Delaware (0.06%), Forte Capital LLC ADV (0.04%), Cardinal Capital Management (0.03%) and Louisiana State Employees Retirement System (0.02%). Company insiders that own Masimo stock include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

MASI stock was sold by a variety of institutional investors in the last quarter, including B & T Capital Management DBA Alpha Capital Management, State of Alaska Department of Revenue, FinTrust Capital Advisors LLC, Cardinal Capital Management, Janney Montgomery Scott LLC and NEXT Financial Group Inc. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo.

MASI stock was acquired by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, Forte Capital LLC ADV, Scout Investments Inc., Boston Trust Walden Corp, Patten Group Inc., Bowling Portfolio Management LLC, Red Spruce Capital LLC and Diversified Trust Co. View Insider Buying and Selling for Masimo.

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MASI stock can currently be purchased for approximately $170.00.

Masimo has a market capitalization of $9.07 billion and generates $858.29 million in revenue each year. The medical equipment provider earns $193.54 million in net income (profit) each year or $3.03 on an earnings per share basis. Masimo employs 1,500 workers across the globe.View Additional Information About Masimo.

The official website for Masimo is http://www.masimo.com/.

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]